Senator Elizabeth Warren criticized UnitedHealth Group's (UNH) $3.3 billion purchase of Amedisys, arguing it gives the company more power to raise costs and deny care, and called for breaking up the company. On November 2, 2026, the nonprofit BetterInvesting named UnitedHealth its “Undervalued Stock” in its January–February 2027 issue, stating the list is for educational purposes and is not an endorsement by NAIC/BetterInvesting. UnitedHealth shares traded at $399.90, down 1.74% on the day and 4.35% over the week, though still up 23.51% this year. Third-quarter adjusted EPS came in at $4.69, above the $4.15 estimate, and the company raised its 2026 adjusted EPS guidance to at least $20.50. Medicare Advantage membership has fallen by 935,000 since year-end 2025, and Warren co-sponsored the Patients Before Monopolies Act (S. 4509).
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
UnitedHealthhealthcaremergers and acquisitionsvaluation
Open a keyword to see other news on the same topic.
Related news
- Is UnitedHealth Group Stock a Buy After Another Solid Quarter?
UnitedHealth beat expectations in Q3, with revenue of $112.7 billion (versus $113.2 billion a year earlier and $111.4 billion expected) and adjusted EPS of $4.69 against Wall Street's $4.14 estimate. The company raised its full-year adjusted EPS guidance to at least $20.50, from the previous $19.50 to $20, helped by exiting unprofitable markets and investing in AI. The stock closed just over $401 last week and is up around 22% in 2026, though its five-year returns remain negative. The article says the forward P/E of around 16 is below the more than 19 times that the average S&P 500 stock trades at, and the 2.3% dividend yield adds appeal for income investors. It concludes UnitedHealth remains a worthwhile option given its modest valuation and improving earnings.
- UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
UnitedHealth's adjusted earnings per share rose about 61% year over year in the third quarter of 2026, beating Wall Street expectations, while revenue also topped forecasts. Management raised full-year adjusted EPS guidance to at least $20.50, up from the previous range of $19.50 to $20.00. The improvement came mainly from more disciplined pricing and better medical cost control, with the medical care ratio falling to 88.4% from 89.9%. Optum Health's operating earnings reached $735 million, compared with $41 million a year earlier. The stock trades at a P/E of about 23, and 26 analysts give a consensus Strong Buy with targets between $380 and $529, though risks include membership declines, medical costs and stricter regulation.
- UnitedHealth ( UNH ): Does Optum Truly Diversify Its Earnings Risk ?
- UnitedHealth Group Incorporated ( UNH ) – What Are Analysts Thinking About This Stock ?
- UnitedHealth keeps medical costs under control — and raises its outlook again
UnitedHealth said its medical-cost ratio was 88.4% in the third quarter of this year, as it works to rein in spending on medical care. The headline says the company kept medical costs under control and raised its outlook again.
- UnitedHealth Group Incorporated Q3 2026 Earnings Call Summary
Related markets
Latest news
- ELEKTROS (OTC:ELEK) Evaluates Northern New York Lithium Opportunity as U.S. Demand for Critical Minerals Takes Center Stage
ELEKTROS Inc. (OTC PINK: ELEK) is evaluating a potential hard-rock lithium opportunity in northern New York near the Canadian border, but the review is at an early exploratory stage, with no completed acquisition and no independently verified mineral resource or reserve. The article cites remarks by Elon Musk and President Donald Trump on the importance of lithium-ion batteries and critical minerals, but notes these statements do not refer to the property under review and do not indicate any government contract or endorsement. Further steps could include confirming ownership and mineral rights, obtaining independent geological analysis, reviewing environmental and permitting requirements, and assessing infrastructure and logistics. The company is also exploring development relationships for its multi-port EV charging patent, but treats this as a separate activity and has not announced a prototype, patent license, or revenue tied to it.
- Ternus touts Apple's $600B US manufacturing pledge on Q4 earnings call
Apple says its American manufacturing program is deepening partnerships with suppliers nationwide. Among them are Perimen, a titanium producer supplying the iPhone Duo, and Qunedy Electronics, which makes the camera technology behind the variable aperture system in the iPhone 18 Pro. Nearly 100 components in the company's newest iPhones come from American companies in more than a dozen states. Apple says it supports more than 450,000 American jobs through thousands of suppliers and partners across all 50 states, as part of its $600 billion four-year commitment to US innovation and advanced manufacturing.
- i-80 Gold Reports Third Quarter 2026 Results; Archimedes Underground on Track to Begin Production Mining by Year-End
i-80 Gold reported third-quarter 2026 revenue of $32.7 million from 7,744 ounces of gold sold at an average realized price of $4,211 per ounce, with production of 11,685 ounces, marginally lower than 12,428 ounces a year earlier. The net loss widened to $48.4 million from $41.9 million, mainly due to higher drilling costs at the Ruby Hill property, while gross profit rose to $5.0 million on a higher realized gold price. The Granite Creek underground project declared initial Mineral Reserves of 556,500 ounces of gold, and the Archimedes underground is on track to begin production mining before year-end 2026. The company targets annual gold production of 150,000 to 200,000 ounces in 2028 and 400,000 to 500,000 gold equivalent ounces in the early 2030s, with Mineral Point open pit now prioritized for a pre-feasibility study.
- Memory Headwinds Are 'Unprecedented'
Apple says memory-related headwinds will not go away anytime soon. The company expects them to keep weighing on its margins for the next several quarters.
- Stock Market Today, Nov. 2: Apple Stock Slides Ahead of Earnings, but Its Latest Results Tell a Different Story
Apple shares fell 1.83% to $338.32 on Monday amid a broader technology sell-off. After the close, Apple reported fiscal fourth-quarter earnings that beat expectations, with revenue of $114.5 billion and earnings of $2.10 per share, supported by strong demand for the iPhone 18. iPhone revenue rose about 17% year over year to $57.6 billion. However, gross margin fell to 47.9% from 50.1% in the previous quarter, reflecting higher component costs and a smaller benefit from tariff refunds, while sales in China and the iPad business fell short of expectations. The S&P 500 fell 0.50% to 7,542 and the Nasdaq Composite lost 1.07% to 25,164.
- AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia
Advanced Micro Devices will report third-quarter results after the market closes Tuesday, after shares fell nearly 11% on Friday and declined again Monday amid broader chip stock weakness, leaving the stock nearly 30% below its all-time high reached less than a month earlier. AMD guided revenue of about $13 billion, plus or minus $300 million, while analysts expect $13.09 billion, up 41.5% from a year ago. The article points to fourth-quarter guidance, especially data center GPU contribution as Helios systems ramp, as the more important figure, with the average analyst estimate at about $16.3 billion and Jefferies' Blayne Curtis expecting closer to $17 billion. Compared with Nvidia's $89 billion of data center revenue last quarter, AMD's data center segment generated $6.7 billion, and the article flags risks including lower margins on AI chips and Intel's warning about a shrinking PC market.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.